Preclinical and clinical evaluation of POONAI MEESAI CHOORANAM KUDINEER (Oral administration) in the management of NEPHROTIC SYNDROME
Phase 2
Completed
- Conditions
- Health Condition 1: N049- Nephrotic syndrome with unspecified morphologic changes
- Registration Number
- CTRI/2022/03/040774
- Lead Sponsor
- Dr P Narmatha
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 40
Inclusion Criteria
Oedema due to renal impairment
Exclusion Criteria
Children above 12 years
Children below 3 years
Hypothyroidism
Cushing syndrome
Oedema due to drug allergy
Oedema mimics obesity in children
Acute glomerular nephritis
Chronic glomerular nephritis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method REDUCTION IN SYMPTOMSTimepoint: 21 days
- Secondary Outcome Measures
Name Time Method ILTimepoint: NI